Unrecognized Tax Benefits of BridgeBio Pharma, Inc. from 31 Dec 2017 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of unrecognized tax benefits.
Summary
BridgeBio Pharma, Inc. quarterly Unrecognized Tax Benefits in USD history and change rate from 31 Dec 2017 to 31 Dec 2025.
  • BridgeBio Pharma, Inc. Unrecognized Tax Benefits for the quarter ending 31 Dec 2025 was $43,979,000, a 19% increase year-over-year.
Source SEC data
View on sec.gov
Unrecognized Tax Benefits, Quarterly (USD)
Unrecognized Tax Benefits, YoY Quarterly Change (%)

BridgeBio Pharma, Inc. Quarterly Unrecognized Tax Benefits (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $43,979,000 +$7,113,000 +19% 31 Dec 2025 10-K 24 Feb 2026 2025 FY
Q4 2024 $36,866,000 +$6,010,000 +19% 31 Dec 2024 10-K 24 Feb 2026 2025 FY
Q4 2023 $30,856,000 +$3,843,000 +14% 31 Dec 2023 10-K 24 Feb 2026 2025 FY
Q4 2022 $27,013,000 +$5,759,000 +27% 31 Dec 2022 10-K 20 Feb 2025 2024 FY
Q4 2021 $21,254,000 +$8,730,000 +70% 31 Dec 2021 10-K 22 Feb 2024 2023 FY
Q4 2020 $12,524,000 +$4,920,000 +65% 31 Dec 2020 10-K 23 Feb 2023 2022 FY
Q4 2019 $7,604,000 +$6,422,000 +543% 31 Dec 2019 10-K 25 Feb 2022 2021 FY
Q4 2018 $1,182,000 +$886,000 +299% 31 Dec 2018 10-K 25 Feb 2021 2020 FY
Q4 2017 $296,000 31 Dec 2017 10-K 03 Mar 2020 2019 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.